1. Speech and language therapy in primary progressive aphasia: a critical review of current practice
- Author
-
Lyndsey Nickels, Cathleen Taylor-Rubin, and Karen Croot
- Subjects
medicine.medical_specialty ,Language therapy ,Disease ,Audiology ,Speech Therapy ,Speech therapy ,Primary progressive aphasia ,03 medical and health sciences ,0302 clinical medicine ,Aphasia ,otorhinolaryngologic diseases ,medicine ,Dementia ,Humans ,Speech ,Pharmacology (medical) ,Speech-language therapy ,business.industry ,General Neuroscience ,Neurodegenerative Diseases ,respiratory system ,medicine.disease ,030227 psychiatry ,Aphasia, Primary Progressive ,Current practice ,Language Therapy ,Neurology (clinical) ,medicine.symptom ,business ,030217 neurology & neurosurgery - Abstract
Primary progressive aphasia (PPA) is a complex language-led dementia syndrome whereby disproportionate deterioration of speech and language occurs subsequent to neurodegenerative disease in the early to mid-stages of the condition. As no effective pharmacotherapies are currently available, speech and language therapies are the optimum treatment to maximize communication for as long as possible.The authors present an overview of current speech-language therapy practices in PPA, highlighting recent research on effective treatments.The challenges in this complex field of practice are described. We highlight the challenge of improving access to speech-language therapy by advocating for increased referral rates. The authors also suggest effective incorporation of innovative technologies in treatment and an enhanced evidence base for the utility of lexical retrieval treatment in improving everyday communication as challenges for the future. Finally, increased provision of PPA-specific education and support for individuals and their families is required.
- Published
- 2021